Efficacy of Adding Oral N acetyl Cysteine Supplement to the Cystic Fibrosis Treatment Regimen: A Randomized Quasi-Experimental Trial.
primary studies published RCT
Details- 2025
- Keshavarz S
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Extension Study.
primary studies published RCT
Details- 2025
- Daines CL
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis.
primary studies published RCT
Details- 2025
- West NE
MetaNeb Versus Usual Care During Exacerbations of Cystic Fibrosis: An RCT.
primary studies published RCT
Details- 2025
- Chapman N
Randomized Cross-Over Analysis of the Influence of Nitrogen Multiple Breath Washout on Spirometry in Monitoring Lung Function in Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia.
primary studies published RCT
Details- 2025
- Schoop AC
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): Results of a multi-centre randomised controlled trial.
primary studies published RCT
Details- 2025
- Plant BJ
The impact of probiotics on pulmonary, gastrointestinal, and growth outcomes in pediatric cystic fibrosis: a randomized controlled trial.
primary studies published RCT
Details- 2025
- Rahmani P
Insulin for early glycaemic abnormality in children with cystic fibrosis without cystic fibrosis-related diabetes (CF-IDEA): a randomised controlled trial.
primary studies published RCT
Details- 2025
- Hameed S
Elexacaftor/tezacaftor/ivacaftor in children aged â¥6â years with cystic fibrosis heterozygous for F508del and a minimal function mutation: Results from a 96-week open-label extension study.
primary studies published RCT
Details- 2025
- Mall MA
The Effects of Progressive Muscle Relaxation on Mental Health and Sleep Quality in Adults with Cystic Fibrosis: A Randomized Controlled Trial.
primary studies published RCT
Details- 2025
- Maritescu A